RT Journal Article
T1 [Spanish translation and cross-cultural adaptation of the ARMS-scale for measuring medication adherence in polypathological patients].
T2 Traducción y adaptación transcultural al español del cuestionario ARMS para la medida de la adherencia en pacientes pluripatológicos.
A1 González-Bueno, Javier
A1 Calvo-Cidoncha, Elena
A1 Sevilla-Sánchez, Daniel
A1 Espaulella-Panicot, Joan
A1 Codina-Jané, Carles
A1 Santos-Ramos, Bernardo
K1 ARMS scale
K1 Adaptación transcultural
K1 Adherence
K1 Adherencia
K1 Cross-cultural adaptation
K1 Cuestionario ARMS
K1 Multimorbidity
K1 Paciente pluripatológico
K1 Traducción
K1 Translation
AB Translate the ARMS scale into Spanish ensuring cross-cultural equivalence for measuring medication adherence in polypathological patients. Translation, cross-cultural adaptation and pilot testing. Secondary hospital. (i)Forward and blind-back translations followed by cross-cultural adaptation through qualitative methodology to ensure conceptual, semantic and content equivalence between the original scale and the Spanish version. (ii)Pilot testing in non-institutionalized polypathological patients to assess the instrument for clarity. The Spanish version of the ARMS scale has been obtained. Overall scores from translators involved in forward and blind-back translations were consistent with a low difficulty for assuring conceptual equivalence between both languages. Pilot testing (cognitive debriefing) in a sample of 40 non-institutionalized polypathological patients admitted to an internal medicine department of a secondary hospital showed an excellent clarity. The ARMS-e scale is a Spanish-adapted version of the ARMS scale, suitable for measuring adherence in polypathological patients. Its structure enables a multidimensional approach of the lack of adherence allowing the implementation of individualized interventions guided by the barriers detected in every patient.
YR 2017
FD 2017-04-05
LK http://hdl.handle.net/10668/11070
UL http://hdl.handle.net/10668/11070
LA es
DS RISalud
RD Apr 11, 2025